Articles tagged with "drug"

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel | July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

Gretchen Henkel | July 1, 2014

Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals

Staff | July 1, 2014

Rheumatology’s premier event to be held in Boston from Nov. 14–19

Teaching Rheumatology in Haiti

Ronald J. Anderson, MD | July 1, 2014

Rheumatologist Ronald J. Anderson, MD, describes volunteer experience with medical residents, teaching rheumatology

Malpractice Lawsuit Fear Provokes Defensive Medicine Response

Simon M. Helfgott, MD | July 1, 2014

Minimizing exposure to malpractice litigation has affected how physicians practice medicine

Rheumatologists May Help Patients with Rheumatoid Arthritis Overcome Obstacles to Sex

David C. Holzman | July 1, 2014

By asking about their sexual relationships, rheumatologists can improve quality of patients’ love lives

Malignant Atrophic Papulosis Is Challenging to Diagnose, Treat

Aixa Toledo-Garcia, MD, Jessica Farrell, PharmD, & Lee Shapiro, MD | July 1, 2014

Patient histories, clinician reports of condition also called Köhlmeier-Degos disease underscore need for integrated, multidisciplinary care

What’s New in Inflammatory Arthritis?

Thomas R. Collins | June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

New Osteoporosis Drugs Show Promise in Therapy Pipeline

Thomas R. Collins | June 1, 2014

Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options